Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Time Course of Drug Effect01:14

Time Course of Drug Effect

The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it produces...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Early diagnosis of subtype in early clinical stage lung adenocarcinoma by using an autoantibody panel and computed tomography].

Zhonghua yi xue za zhi·2019
Same author

Influence of ERCC2 gene polymorphisms on the treatment outcome of osteosarcoma.

Genetics and molecular research : GMR·2015
Same author

Quantification of Angiotensin peptides.

Methods in molecular medicine·2011
Same author

Neuronal angiotensin-converting enzyme (ACE) gene expression is increased by converting enzyme inhibitors (CEI).

Molecular and cellular neurosciences·2009
Same author

Gene therapy for hypertension and restenosis.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?

Physiological genomics·2002

Related Experiment Video

Updated: Jun 4, 2026

Nitropeptide Profiling and Identification Illustrated by Angiotensin II
07:31

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Quantification of Angiotensin-Converting Enzyme (ACE) Activity.

Q C Meng1, K H Berecek

  • 1Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, AL.

Methods in Molecular Medicine
|February 19, 2011
PubMed
Summary

Accurate measurement of tissue angiotensin-converting enzyme (ACE) activity is crucial. This enzyme regulates blood pressure and is vital in local tissue functions, necessitating reliable measurement methods.

More Related Videos

Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI)
08:57

Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI)

Published on: August 18, 2017

Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney
10:00

Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney

Published on: October 12, 2015

Related Experiment Videos

Last Updated: Jun 4, 2026

Nitropeptide Profiling and Identification Illustrated by Angiotensin II
07:31

Nitropeptide Profiling and Identification Illustrated by Angiotensin II

Published on: June 16, 2019

Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI)
08:57

Peptide and Protein Quantification Using Automated Immuno-MALDI (iMALDI)

Published on: August 18, 2017

Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney
10:00

Use of Enzymatic Biosensors to Quantify Endogenous ATP or H2O2 in the Kidney

Published on: October 12, 2015

Area of Science:

  • Biochemistry
  • Physiology
  • Enzymology

Background:

  • Angiotensin-converting enzyme (ACE) is a key enzyme in blood pressure regulation.
  • ACE exists in soluble and membrane-bound forms, with local tissue roles increasingly recognized.
  • Local renin-angiotensin system (RAS) in organs like the heart and kidney highlights the importance of membrane-bound ACE.

Purpose of the Study:

  • To emphasize the importance of accurate measurement of tissue-bound ACE activity.
  • To highlight the role of ACE in local tissue functions beyond plasma activity.
  • To underscore the need for reliable methods for both soluble and membrane-bound ACE activity assessment.

Main Methods:

  • The abstract does not specify methods but discusses the physiological action and localization of ACE.
  • It implies the need for biochemical assays to measure enzyme activity.
  • Focus is on the importance of measurement rather than specific techniques.

Main Results:

  • ACE (EC 3.4.15.1) converts angiotensin I to angiotensin II, regulating blood pressure and fluid balance.
  • Membrane-bound ACE is found in endothelial and epithelial cells, playing roles in local RAS.
  • Local RAS in the heart and vasculature is implicated in hypertrophy and remodeling.

Conclusions:

  • Accurate and reliable methods for measuring tissue (membrane-bound) ACE activity are essential.
  • Understanding soluble ACE activity also remains important.
  • The localized action of ACE in various organs necessitates specific measurement techniques.